Nanoviricides (NNVC) Total Non-Current Liabilities (2013 - 2019)
Nanoviricides' Total Non-Current Liabilities came in at $1.08 million for fiscal Q3 2019 (quarter ended Mar 31, 2019), down 52.7% from $2.29 million a year earlier.
Powered by 
Analysis
Nanoviricides (NNVC) Total Non-Current Liabilities (2013 - 2019) Analysis & Trends
At the end of FY2018 (ended Jun 30, 2018), Nanoviricides' Total Non-Current Liabilities was $881,948, down 56.2% from FY2017.
- Total Non-Current Liabilities has declined in each of the last four fiscal years, with a five-year compound annual growth rate of -34.3% (FY2013 to FY2018).
- Going back by fiscal year, Total Non-Current Liabilities was $2.02 million in FY2017 (-70.5%), $6.84 million in FY2016 (-42.0%), $11.8 million in FY2015 (-40.9%) and $19.97 million in FY2014 (+176.6%).
- The five-year range for quarterly Total Non-Current Liabilities is $881,948 (fiscal Q4 2018) to $19.97 million (fiscal Q4 2014).
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q4 2014 (growth of 176.6%), and the weakest in fiscal Q1 2018 (a decline of 79.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Nanoviricides | 30.18 Mn | 17.84 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 1.08 Mn |
| Jun 30, 2018 | 881,948.00 |
| Mar 31, 2018 | 2.29 Mn |
| Dec 31, 2017 | 1.58 Mn |
| Sep 30, 2017 | 1.46 Mn |
| Jun 30, 2017 | 2.02 Mn |
| Mar 31, 2017 | 5.84 Mn |
| Dec 31, 2016 | 5.90 Mn |
| Sep 30, 2016 | 7.06 Mn |
| Jun 30, 2016 | 6.84 Mn |
| Mar 31, 2016 | 7.72 Mn |
| Dec 31, 2015 | 11.00 Mn |
| Sep 30, 2015 | 10.60 Mn |
| Jun 30, 2015 | 11.80 Mn |
| Mar 31, 2015 | 13.22 Mn |
| Dec 31, 2014 | 7.69 Mn |
| Sep 30, 2014 | 16.08 Mn |
| Jun 30, 2014 | 19.97 Mn |
| Mar 31, 2014 | 11.79 Mn |
| Dec 31, 2013 | 14.44 Mn |
API Access
Nanoviricides Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();